Osteonecrose Perimplantar Relacionada ao Uso de Bisfosfonatos: Revis�o de Literatura

Rafaela Fonseca Rigo; Rafaela Fonseca Rigo; Fernando Vacilotto Gomes; Luciano Mayer; Luciano Mayer

Osteonecrose Perimplantar Relacionada ao Uso de Bisfosfonatos: Revis�o de Literatura

Rafaela Fonseca Rigo, Rafaela Fonseca Rigo, Fernando Vacilotto Gomes, Luciano Mayer, Luciano Mayer

Resumo

O uso de implantes dent�rios na reabilita��o oral de pacientes vem sendo amplamente empregado. No entanto, o uso de algumas medica��es, entre elas, os bisfosfonatos, est�o sendo associadas como um fator de risco para o insucesso no tratamento com implantes por estar relacionada ao aparecimento de osteonecrose nos maxilares. Portanto, essa monografia tem por objetivo fazer uma revis�o de literatura nas principais bases de dados dispon�veis sobre os efeitos do uso sist�mico dos bisfosfonatos associado a implantes dent�rios. A maioria dos estudos mostraram que pacientes que receberam tratamento com bisfosfonato para algum tipo de desordem sist�mica, seja administrado por via oral ou sist�mica, aumentaram o risco para o desenvolvimento de algum tipo de osteonecrose dos maxilares em �reas onde foi realizada cirurgia para coloca��o de implantes dent�rios. No entanto, mais pesquisas devem ser realizadas para melhor elucidar as consequ�ncias e tratamento para a ocorr�ncia desse problema ap�s procedimentos odontol�gicos.

Palavras-chave

Implantes dent�rios; Bifosfonatos; Osteonecrose.

Texto completo:

PDF

Refer?ncias

Yip JK et al. Association between oral bisphos-phonate use and dental implant failure among middle-aged women. J Clin Periodontol 2012;39(4):408-414.

Thirunavurakasu A, Pinto HG, Seymour KG. Bisphosphonate and implant dentistry Is it safe? Prim Dent J 2015; 4(2):30-33.

Sanchez MPR. et al. Implantes osseointegrados em pacientes com doen�as do metabolismo �sseo tratadas com bisfosfonatos. INPerio 2016;1(1):84-94.

Wada, T. et al. RANKLRANK signaling in os-teoclastogenesis and bone disease. Trends Mol Med 2006; 12(1):17-25.

AAOMS. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65(3):369-376.

Marx RE, Cillo JE, Ulloa JJ. Oral bisphospho-nate-induced osteonecrosis: risk factors, predic-tion of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65(12):2397-2410.

Grant BT et al. Outcomes of Placing Dental Im-plants in Patients Taking Oral Bisphosphonates: A Review of 115 Cases. J Oral Maxillofac Surg 2008;66(2):223-230.

Bell MB, Bell RE. Oral Bisphosphonates and Dental Implants: A Retrospective Study. J Oral Maxxilofac Surg 2008;66(5):1022-1024.

Ruggiero SL et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication Related Osteonecrosis of the Jaw 2014 Update. J Oral Maxillofac Surg 2014;72(10):1938-1956.

Shabestari GO et al. Implant Placement in Pa-tients with Oral Bisphosphonate Therapy: A Case Series. Clin Implant Dent Relat Res 2010;12(3):175-180.

Kwon YD et al. Retrospective study of two bio-chemical markers for the risk assessment of oral bisphosphonate-relatedosteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 2011;22(1):100-105.

Lazarovici TS et al. Bisphosphonate-Related Osteonecrosis of the Jaw Associated with Dental Implants. J Oral Maxillofac Surg 2010;68(4):790-796.

Kim HJ, Park TJ, Ahn KM. Bisphospho-nate-related osteonecrosis of the jaw in metastatic breast c�ncer patients: a rewiew of 25 cases. Maxillofac Plast Reconstr Surg 2016;38(6):e1-8.

Kwon TG et al. Osteonecrosis associated with dental implants in patients undergoing bisphos-phonate treatment. Clin Oral Implants Res 2014;25(5):632-640.

Borromeo GL et al. Is bisphosphonate therapy for benign bone disease associated with impaired dental healing: A case-controlled study. BMC Musculoskelet Disord 2011;12(71):1-10.

Oconnell JE, Ikeagwani O Kearns GJ. A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphospho-nate-related osteonecrosis of the jaws (BRONJ) following oral surgery? Ir J Med Sci 2012;181(2):237-242.

Flichy-Fern�ndez AJ et al. Study of serum CTX in 50 oral surgical patients treated with oral bisphosphonates. Med Oral Patol Oral Cir Bucal 2012;17(3):367-370.

Abtahi J et al. Effect of local vs. Systemic bisphosphonate delivery on dental implant fixa-tion in a model of osteonecrosis of the jaw. J Dent Res 2013;92(3):279-283.

Jacobsen C et al. Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig 2013;17(1):167-175.

L�pez-Cedr�n JL et al. Oral bisphospho-nate-related osteonecrosis of the jaws in dental implant patients: a case series. Br J Oral Maxil-lofac Surg 2013;51(8):874-879.

Holzinger D et al. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2014;72(10):p.1937.

Mozzati M et al. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic woman under bisphosphonate therapy. J Craniofac Surg 2015;26(3):749-755.

Nisi M. et al. Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis. Int J Oral Maxillofac Surg 2015;44(5):586-591.

Matsuo A et al. Evaluation of dental implants as a risk factor for the development of bisphospho-nate-related osteonecrosis of the jaw in breast cancer patients. Odontology, May, 2015.

Kim HJ et al. Bisphosphonate-related osteone-crosis of the jaw in metastatic breast c�ncer pa-tients: a rewiew of 25 cases. Maxillofac Plast Reconstr Surg 2016;38(6):e1-8.